This article is more than 5 years old. Information may no longer be current.

Joimax receives FDA clearance for EndoLIF On-Cage implant

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

German company Joimax announced it has received 510(k) clearance from the FDA to market its Endoscopic Lumbar Interbody Fusion, or EndoLIF, On-Cage implant, according to a company press release.

The new system is built from titanium alloy produced with electron beam melt technology. Additionally, the cage has a porous surface with diamond cell structure and two large openings, which may be filled with autogenous bone, to support the creation of a straight column for fusion.

EndoLIF is designed to enable surgeons to use an intermuscular approach, similar to a mini-transforaminal lumbar interbody fusion, into the intervertebral disc, and it is designed to be used with supplemental posterior fixation. The implantation can be performed using a posterior or posterolateral approach, with either an open or endoscopic-assisted method, according to the release.

Reference: www.joimax.com.